Company intelligence / Profile preview

SMC Laboratories

Ownership: Private
Employees: ~29
Development stage: Commercial

Overview

SMC Laboratories is a leading Japanese non-clinical CRO specializing in drug efficacy evaluation studies using advanced animal models—most notably the STAM™ mouse—for diseases such as MASH/NASH-HCC. The company has supported over 1,000 clients worldwide with pharmacology studies that are highly translatable to clinical research. Its services have contributed to the advancement of multiple client programs into clinical trials for liver diseases and other fibrotic/inflammatory conditions[1][4][6].

Therapeutic areas: PulmonologyOncologyEndocrinologyRheumatologyNeurologyGastroenterologyNephrology
Modalities: Small moleculeBiologic
Industry: Contract Research Organization

Partnerships

Galectin TherapeuticsCan-Fite BioPharmaDevonian Health Group Inc.

Beyond the preview

Go deeper on SMC Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SMC Laboratories.

Explore the full profile